| Year |
Citation |
Score |
| 2017 |
Lal S, Raffel C. Using Cystine Knot Proteins as a Novel Approach to Retarget Oncolytic Measles Virus Molecular Therapy - Oncolytics. 7: 57-66. PMID 29367943 DOI: 10.1016/J.Omto.2017.09.005 |
0.366 |
|
| 2016 |
Lal S, Peng KW, Steele MB, Jenks N, Ma H, Kohanbash G, Phillips JJ, Raffel C. Safety study: Intraventricular injection of a modified oncolytic measles virus into measles-immune, hCD46-transgenic, IFNαRko mice. Human Gene Therapy. Clinical Development. PMID 27604429 DOI: 10.1089/Humc.2016.062 |
0.319 |
|
| 2016 |
Svalina MN, Kikuchi K, Abraham J, Lal S, Davare MA, Settelmeyer TP, Young MC, Peckham JL, Cho YJ, Michalek JE, Hernandez BS, Berlow NE, Jackson M, Guillaume DJ, Selden NR, et al. IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma. Scientific Reports. 6: 27012. PMID 27255663 DOI: 10.1038/Srep27012 |
0.342 |
|
| 2015 |
Lal S, Kersch C, Beeson KA, Wu YJ, Muldoon LL, Neuwelt EA. Interactions between αv-Integrin and HER2 and Their Role in the Invasive Phenotype of Breast Cancer Cells In Vitro and in Rat Brain. Plos One. 10: e0131842. PMID 26222911 DOI: 10.1371/Journal.Pone.0131842 |
0.394 |
|
| 2015 |
Svalina MN, Kikuchi K, Abraham J, Lal S, Davare MA, Peckham JL, Cho Y, Jackson M, Guillaume DJ, Selden NR, Bigner DD, Nazemi KJ, Green SC, Corless CL, Gultekin S, et al. Abstract A08: IGF1R as a key target in high risk, metastatic medulloblastoma Brain. 75. DOI: 10.1158/1538-7445.Brain15-A08 |
0.399 |
|
| 2015 |
Lal S, Raffel C. Atps-70Using Cysteine Knot Proteins To Retarget An Oncolytic Virus To Novel Cell Surface Antigens Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov204.70 |
0.384 |
|
| 2014 |
Davare MA, Lal S, Peckham JL, Prajapati SI, Gultekin SH, Rubin BP, Keller C. Secreted meningeal chemokines, but not VEGFA, modulate the migratory properties of medulloblastoma cells. Biochemical and Biophysical Research Communications. 450: 555-60. PMID 24928387 DOI: 10.1016/J.Bbrc.2014.06.018 |
0.42 |
|
| 2014 |
Lal S, Lawrence S, Raffel C. Nt-17Treatment Of Diffuse Intrinsic Pontine Glioma (Dipg) With An Oncolytic Measles Virus In Combination With Inhibitors Of The Pi3-Kinase Pathway Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou265.16 |
0.394 |
|
| 2013 |
Lal S, Wu YJ, Muldoon LL, Neuwelt EA. Abstract 1642: The role of αv integrin in melanoma cell migration and invasion. Cancer Research. 73: 1642-1642. DOI: 10.1158/1538-7445.Am2013-1642 |
0.426 |
|
| 2012 |
Lal S, La Du J, Tanguay RL, Greenwood JA. Calpain 2 is required for the invasion of glioblastoma cells in the zebrafish brain microenvironment Journal of Neuroscience Research. 90: 769-781. PMID 22183788 DOI: 10.1002/Jnr.22794 |
0.559 |
|
| 2012 |
Ohshima-Hosoyama S, Davare MA, Prajapati SI, Abraham J, Lal S, Nelon LD, Kilcoyne A, Giles FJ, Hanes MA, Rubin BP, Keller C. Preclinical testing of tandutinib in a transgenic medulloblastoma mouse model. Journal of Pediatric Hematology/Oncology. 34: 116-21. PMID 22146535 DOI: 10.1097/Mph.0B013E3182309Fe4 |
0.34 |
|
| 2010 |
Jang HS, Lal S, Greenwood JA. Calpain 2 is required for glioblastoma cell invasion: Regulation of matrix metalloproteinase 2 Neurochemical Research. 35: 1796-1804. PMID 20730561 DOI: 10.1007/S11064-010-0246-8 |
0.569 |
|
| 2008 |
Sprague CR, Fraley TS, Hyo SJ, Lal S, Greenwood JA. Phosphoinositide binding to the substrate regulates susceptibility to proteolysis by calpain Journal of Biological Chemistry. 283: 9217-9223. PMID 18258589 DOI: 10.1074/Jbc.M707436200 |
0.487 |
|
| Show low-probability matches. |